Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nature Medicine 2003, 9:669–676.PubMedCrossRef 24. Piossek C, Schneider-Mergener J, Schirner M, Vakalopoulou E,

Germeroth L, Thierauch KH: Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF. Journal of Biological Chemistry 1999, 274:5612–5619.PubMedCrossRef 25. Arany Z, Foo SY, Ma YH, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, et al.: HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1 alpha. Nature 2008, 451:1008-U1008.PubMedCrossRef 26. Pan Q, Z-VAD-FMK in vivo Chanthery Y, Liang WC, Stawicki S, Mak J, Rathore N, Tong RK, Kowalski J, Yee SF, Pacheco G, et al.: Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 2007, 11:53–67.PubMedCrossRef 27. Li MY, Lee TW, Mok TSK, Warner TD, Yim APC, Chen GG: Activation of peroxisome proliferator-activated receptor-gamma APR-246 in vivo by troglitazone (TGZ) inhibits human lung cell growth. Journal of Cellular

Biochemistry 2005, 96:760–774.PubMedCrossRef 28. Regina S, Rollin J, Blechet C, Iochmann S, Reverdiau P, Gruel Y: Tissue factor expression in non-small cell lung cancer: Relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. Journal of Thoracic Oncology 2008, 3:689–697.PubMedCrossRef 29. Li M, Hui Y, Chai H, Fisher WE, Wang XP, Brunicardi FC, Yao QZ, Chen CY: Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, oxyclozanide but not vascular endothelial growth factor receptors. Cancer 2004, 101:2341–2350.PubMedCrossRef 30. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1–8.PubMedCrossRef 31. Weidner N, Carroll PR, Flax J,

Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology 1993, 143:401–409.PubMed 32. Gorski DH, Leal AD, Goydos JS: Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression. 2003, 408–418. 33. Hicklin DJ, Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of Sorafenib research buy Clinical Oncology 2005, 23:1011–1027.PubMedCrossRef 34. Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, Kim PJ, Owens RJ, Lang NP: Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. 2007, 1476–1481. 35. Zhang W, Zhang H, Xing L: Influence of ciglitazone on A549 cells growth in vitro and in vivo and mechanism. J Huazhong Univ Sci Technolog Med Sci 2006, 26:36–39.PubMedCrossRef 36.

burnetii infected THP-1 cells regardless of ongoing bacterial protein C59 wnt synthesis. These results confirm that genes with significant mRNA expression changes by oligonucleotide microarrays analysis are differentially expressed when measured by RT-qPCR. Figure 4 RT-qPCR of selected genes confirms microarray expression trends. A, shows the microarray data of the Selleckchem AZD1480 genes used to confirm microarray expression trends. Fold difference (-CAM)

is the fold change of differentially expressed THP-1 genes in response to C. burnetii infection after mock treatment. Fold difference (+CAM) is the fold change of differentially expressed THP-1 genes in response to C. burnetii infection after CAM treatment. B, difference in mRNA levels in selected genes relative to β-actin. An equal amount of total RNA from each sample was analyzed by RT-qPCR. The Y-axis represents fold changes

in gene expression while X axis shows the conditions under which gene expression was observed (mock and CAM treated, and uninfected and C. burnetii infected THP-1 cells). U-CAM, uninfected THP-1 minus CAM. U+CAM, uninfected THP-1 plus CAM. I-CAM, infected THP-1 minus CAM. I+CAM, infected THP-1 plus CAM. The results represent the mean of three biological samples and three technical replicates of each sample. Error bars represent the s.e.m. Discussion Bacterial effector proteins are crucial to the survival and growth of intracellular pathogens within the eukaryotic cellular environment. These interactions may be at a myriad of pathways or Momelotinib at points within a single pathway. Moreover, the growth of C. burnetii within the lumen of the PV would require the mediation of interactions with the host cell using effector proteins, which are predicted to be delivered by the pathogen’s type IV secretion system [10, 11, 19]. The goal of this study was to identify host genes that are specifically manipulated by C. burnetii proteins. Our hypothesis was that the Amino acid expression of host cell genes will be changed by infection with C. burnetii NMII and that the expression of a subset of these genes will be directly affected by ongoing

bacterial protein synthesis. Identification of such genes will aid in the understanding of host molecular mechanisms being targeted by C. burnetii during growth. In order to identify the host genes regulated by C. burnetii proteins, we compared CAM and mock treated mRNA profiles of THP-1 cells following a 72 h infection with C. burnetii. Microarray data analysis shows that the majority of host genes were up- or down regulated similarly in both the mock and CAM treated array sets, suggesting that most THP-1 genes were not differentially modulated at the RNA level by active C. burnetii protein synthesis. We had predicted that the majority of expression changes in the host cell would be in response to the physical presence of bacteria within the cell.

Therefore, the present study extends the role of Hfq in beneficial nitrogen-fixing bacteria to other processes related to the interaction

with the plant host, further supporting the predicted universal role of Hfq in the establishment and maintenance of chronic intracellular residences regardless the outcome of these infections. Furthermore, we provide click here the first experimental evidence of S. meliloti sRNAs-binding Hfq, thus anticipating the involvement of these molecules at different levels in the complex S. meliloti Hfq regulatory network. Figure 8 Summary of pathways and phenotypes linked to an hfq mutation in S. meliloti. Double BIIB057 nmr arrowheads denote favoured pathways and blocked arrows unfavoured pathways in the absence of Hfq. +O2, aerobic conditions; -O2, microaerobic conditions. Hfq influences growth and central carbon metabolism in S. meliloti Hfq loss-of-function affected the free-living growth of S. meliloti, thus confirming the predicted pleiotropy of this mutation in bacteria. To investigate the molecular basis of this growth deficiency we combined transcriptomic and proteomic profiling of two independent S. meliloti hfq mutants (1021Δhfq and 2011-3.4) exhibiting similar free-living growth

defects. These experiments identified 168 transcripts and 33 polypeptides displaying reliable differential accumulation in the respective mutant and wild-type strains, with 9 genes common to both sets. The BMS202 concentration differences between the wild-type 2011 and 1021 strains could partially explain the limited overlap between proteins and transcripts regulated by Hfq in both genetic backgrounds. However, this has

(-)-p-Bromotetramisole Oxalate been also observed in Salmonella and more likely reflects the differential global effects of this protein on transcription, transcript stability and translation [42]. Nonetheless, both analyses converged in the identification of genes coding for periplasmic solute binding proteins of ABC transporters and metabolic enzymes as the dominant functional categories influenced by an Hfq mutation. The extensive role of Hfq in the regulation of nutrient uptake and central metabolism has been also highlighted by global transcriptome/proteome analyses of other hfq mutants such as those of E. coli, Salmonella tiphymurium, Pseudomonas aeruginosa or Yersinia pestis [15, 43–45]. Furthermore, in Salmonella and E. coli the massive regulation of genes encoding periplasmic substrate-binding proteins of ABC uptake systems for amino acids and peptides involves the Hfq-dependent GcvB sRNA [46]. GcvB homologs of distantly related bacteria conserve a G/U-rich stretch that binds to extended complementary C/A-rich regions, which may serve as translational enhancer elements, in the mRNA targets [46]. The apparent widespread distribution of GcvB RNAs in bacteria suggests that a similar regulatory mechanism for ABC transporters could also exist in S. meliloti.

However, this is not surprising, as similar heterogeneity in the Selleckchem Lonafarnib transcription regulation might exist even among different strains within the same species. Finally, CovRS has been reported to obviously respond to so far unknown molecular signals in human blood. Analysis of GAS global transcription during ex vivo culture in human whole blood revealed that CovRS is involved in GAS adaptation allowing growth in blood [13]. We observed that covS

insertional mutants in the M6, M2 and M18 background were significantly attenuated in their efficiency to multiply in whole human blood, suggesting a high importance of the sensor kinase activity for blood survival. However, this cannot be postulated for M49 591, which is a skin isolate. Moreover, since the adaptation in human blood is associated mainly with pathogenesis during invasive growth, the involvement of CovS to the response to human blood exposure is not a uniform characteristic among different GAS serotype strains. Most recently, a paper published during the review JSH-23 chemical structure process of this work by Trevino and colleagues uncovered that CovR retains some regulatory activity in the absence of a functional CovS sensor kinase and that CovS mutants are hypervirulent in ex vivo and in vivo

models of invasive infection [14]. However, CovS mutants were attenuated in their ability to ARS-1620 purchase survive in human saliva, which could be one possible explanation why no natural CovS mutants are transmitted from host to host [14]. Conclusion Taken together, no serotype-dependent contribution on regulation of capsule expression and adherence to human keratinocytes was observed. Interestingly, an increased capsule expression in M2, M6 and M18 CovS mutants did not lead to enhanced survival of the bacteria in whole human blood. In contrast, Etofibrate the effect of CovS on biofilm formation depended on the examined strain. This finding implies that the CovRS system has divergent

effects on similar target genes in different strains. Thus, the CovRS system could differ with respect to its repertoire of regulated genes in a strain-dependent manner. In summary, in addition to Nra, the CovRS system is the second regulator in GAS with serotype- or even strain-dependent activity, further supporting the emerging scheme of divergent regulatory circuits in GAS. Acknowledgements This research was supported by grants from the Federal Ministry of Education and Research (BMBF) – financed networks “”ERA-NET Pathogenomics”" and SysMo “”Systems Biology of Microorganisms”" awarded to B.K and A.P. (BMBF grants BE031-03U213B, 0313936A and 0313979B) The authors would like to thank Ludwig Jonas from the Electron Microscopy Unit of the University Clinic Rostock for support in obtaining REM pictures, and Jana Normann, Yvonne Humbold, Kathleen Arndt and Lars Middelborg for expert technical assistance.

8% (61) resistance to tetracycline, and 0.3% (3) resistance to rifampin. Macrolide resistance phenotypes and genotypes Two hundred ninety five (32.8%) erythromycin resistant isolates were detected among the 898 GAS isolates gathered over the PLX4032 13-year collection period. The M phenotype was clearly predominant (227 isolates, 76.9%), followed

by the cMLSB (60 isolates, 20.3%) and iMLSB phenotypes (8 isolates, 2.7%) (Table 1). The isolates with the cMLSB phenotype showed high-level resistance to erythromycin and selleck chemical Clindamycin (MIC90 ≥256 mg/L), whereas those with the iMLSB and M phenotypes showed lower erythromycin resistance values and susceptibility to clindamycin (Table 1). To highlight, the cMLSB phenotype was more predominant among invasive that in Selleckchem Acadesine non-invasive, 43.8 and 12.6%, respectively. Table 1 Distribution of phenotypes and genotypes among macrolide-resistant S. pyogenes isolates Phenotype No. isolates (%) Invasive/non-invasive Antimicrobial agent(mg/L) Macrolide resistance genotype       Range MIC50 MIC90 erm (B) erm (A) mef (A) msr (D) None gene M 227 (76.9) Erythromycin 1- ≥ 256 32 128 50 87 224 221 1 38 / 189 Clindamycin 0.06-0.5 0.25 0.5 cMLSB 60 (20.3) Erythromycin 8- ≥ 256 ≥256 ≥256 57 11 36 17 2 32 / 28 Clindamycin

1- ≥ 256 ≥256 ≥256 iMLSB 8 (2.7) Erythromycin 2- ≥ 256 16 32 3 8 4 3 0 3 / 5 Clindamycin 0.06-0.5 0.25 0.5 Total 295 (100) Erythromycin 1- ≥ 256 64 256 110 106 264 241 3 73 /222 Clindamycin 0.06-0.5 0.25 256           In the present work, the mef(A) (89.5%) and msr(D) (81.7%)

genes were the most prevalent macrolide resistance determinants. erm(B) and erm(A) were observed in just 37.3% and 35.9% of isolates Alanine-glyoxylate transaminase respectively (Table 1). Fourteen macrolide resistance genotypes were identified among the 295 erythromycin-resistant isolates (Table 2), with msr(D)/mef(A) (38%) and msr(D)/mef(A)/erm(A)(19.7%) the two most common combination. Both genotypes were associated with the M phenotype. Table 2 Macrolide resistance genotypes of 295 isolates of erythromycin-resistant S. pyogenes , indicating the phenotypes and emm /T types detected Macrolide resistance genotype No. of isolates Phenotypea emm/T typesa (%) cMLSB iMLSB M erm(B) 14 (4.7) 14 – - emm6T6 (1b), emm11T11 (5b) emm28T28 (6c), emm71TNT (1) emm78T11 (1) erm(B)/erm(A) 1 (0.3) 1 – - emm12T12 erm(B)/ msr(D) 5 (1.7) 5 – - emm11T11 (1b), emm28T28 (3) emm88T28 (1) erm(B)/mef(A) 21 (7.1) 20 – 1 emm4T4 (1), emm28T28 (18) emm28TNT(1), emm75T25 (1) erm(B)/ msr(D)/mef(A) 33 (11.2) 8 – 25 emm1T1 (1), emm2T2 (1) emm4T4 (14), emm6T6 (2) emm11T11 (2b), emm12T12 (4) emm28T28 (4), emm75T25 (4) emm84T25 (1) erm(B)/ msr(D)/ erm(A) 2 (0.7) 2 – - emm11T11 (2b) erm(B)/ erm(A)/mef(A) 7 (2.4) 5 2 – emm11T11 (1b), emm28T28 (4) emm77T28 (1b), emm83TNT (1b) erm(B)/ msr(D)/mef(A)/ erm(A) 27 (9.2) 2 1 24 emm1T1 (1), emm4T4 (3) emm11T11 (1), emm12T12 (3) emm75T25 (14),emm81TB3264(1) emm84T25 (4) erm(A)/mef(A) 6 (2.

2). Fig. 7 R 2 for regressions of F v/F m(λex,λem) of simulated

Napabucasin mw communities against F v/F m(470,683) and F v/F m(590,683) of respectively algal and cyanobacterial subpopulations. These plots represent cross sections of the excitation–emission regression matrix of Fig. 6: a the 683-nm emission line, b the 470-nm excitation line, and c the 590-nm excitation line. Key excitation–emission selleck products pairs are indicated by the numeric markers corresponding to Figs. 6 and 8 The data underlying the optimal excitation/emission pairs identified from Figs. 6 and 7 are presented in Fig. 8 with corresponding regression statistics. Figure 8a confirms that community F v/F m(470,683) is strongly driven by the algal F v/F m and was highly insensitive to the fluorescence of the cyanobacteria in the simulated communities. Only the case for equal VX-770 clinical trial absorption in the algal and cyanobacterial subpopulations is shown here, but when the community composition was skewed to 90% in favour of the cyanobacteria, community F v/F m(470,683) remained a good (relative error <10%) predictor of algal F v/F m(470,683) in 92% of cases. The fluorescence emission of the cyanobacterial

fraction was too low at this excitation/emission pair to influence community variable fluorescence, even when mixed with algal cultures of low (variable) fluorescence. Fig. 8 Case plots underlying the linear regression analyses of community F v/F m(λex,λem) versus algal and cyanobacterial F v/F m(470,683) and F v/F m(590,683), respectively. a–c correspond to the key excitation–emission pairs highlighted with numerical markers in Fig. 6. a F v/F m(470,683), sensitive to algal but not cyanobacterial F v/F m, b F v/F m(590,683), with stronger correspondence to cyanobacterial compared to algal F v/F m and c F v/F m(590,650), strongly related to cyanobacterial F v/F m(590,683) >0.4. Colours and symbols correspond to Fig. 7, drawn black lines mark unity. The discrete distribution of the subcommunity F v/F m values is caused by

the limited number of cultures used to simulate community F v/F m matrices Under red–orange illumination centred at 590 nm (Fig. 8b) we note a better correlation of community and cyanobacterial F v/F m (R 2 = 0.54). Y-27632 2HCl The relatively low slope and high offset of this regression were clearly caused by the inclusion of cases where cyanobacterial subpopulations with low F v/F m were mixed with algae with higher F v/F m, a result of a wider spread of F v/F m in the cyanobacterial cultures compared to the algae (Fig. 3). The regression results for the algal fraction under emission at 590 nm were clearly worse with R 2 = 0.18. The variable fluorescence originating from PBS pigments (F v/F m(590,650)) was lower than F v/F m(590,683) while the relation between community and cyanobacterial F v/F m was strong for cyanobacteria cultures with F v/F m >0.42 (Fig. 8c).

KCTC 11604BP. Significant differences in the regulation observed between these two PLX-4720 mw strains obviously have a profound influence on the process development efforts at the industrial scale. Finally, we have demonstrated a potential for FK506 yield increase in engineered strains of S. tsukubaensis by simple overexpression of fkbN and fkbR, which could this website result in rapid and straightforward improvement of FK506 yield in the industrial fermentation process. Acknowledgements We thank the Government of Slovenia, Ministry of Higher Education, Science and Technology (Slovenian Research Agency, ARRS) for the award of Grant No. J4-9331 and No. L4-2188 to Hrvoje Petković. We also thank

the Ministry of the Economy, the JAPTI GKT137831 Agency and the European Social Fund for the funds awarded for employment of Gregor Kosec (contract No. 102/2008). This work was also supported by a Grant of the European Union ERA-IB project EU2008-0333656

to Juan F. Martin. C. Barreiro was supported by the European Union program ERA-IB [BioProChemBB project (EIB.08.008)]. M. Martínez-Castro received a PFU fellowship of the Ministry of Education and Science. We would like to thank Dr. Paul Herron and Prof. Lain Hunter for providing us the ermE* promoter with Streptomyces RBS. Electronic supplementary material Additional file 1: Table containing primers for PCR amplifications of the target putative regulatory genes (The file presents primers and their corresponding sequences, that have been used for PCR amplification of whole genes or homologous regions and promoter regions). (PDF 41 KB) Additional file 2: Schematic representation of FkbR and FkbN protein domains and deleted regions (This file illustrates FkbR and FkbN proteins and their organization before Unoprostone and after inactivation). (PDF 13 KB)

Additional file 3: Primers used for RT-PCR analysis (This file presents a list of primers and their corresponding sequences, that have been used for RT-PCR experiments). (PDF 42 KB) References 1. Thomson AW: FK-506 enters the clinic. Immunol Today 1990,11(2):35–36.PubMedCrossRef 2. Wallemacq PE, Reding R: FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 1993,39(11 Pt 1):2219–2228.PubMed 3. Meingassner JG, Stutz A: Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992,98(6):851–855.PubMedCrossRef 4. Easton JB, Houghton PJ: Therapeutic potential of target of rapamycin inhibitors. Expert Opin Ther Targets 2004,8(6):551–564.PubMedCrossRef 5. Graziani EI: Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs. Nat Prod Rep 2009,26(5):602–609.PubMedCrossRef 6. McDaniel R, Welch M, Hutchinson CR: Genetic approaches to polyketide antibiotics. 1. Chem Rev 2005,105(2):543–558.PubMedCrossRef 7.

These studies may indicate further metabolism of adenosine before PX-478 becoming bioavailable and warrant further investigation. These effects of

ATP and adenosine could account, at least in part, for the improvements in low peak torque and torque fatigue we observed. The current study tested the hypothesis that oral ATP could improve performance during high intensity exercise. While we have shown this may be possible, the current study did not utilize methodologies to investigate the potential mechanism for the effects we observed. Further studies should incorporate measures of ATP and metabolites in blood components, should include measures of blood oxygenation and muscle blood flow, and also should investigate the extracellular role of ATP on the neuromuscular junction via Ca2+ mediated

effects [35] as indicators of the potential mechanism by which oral ATP affects the ability to perform strenuous exercise. Our study, like others in the literature, has limitations. The number of participants in the present study (n=16), while higher than that (n=9) previously studied by Jordan et al. [21], may not be sufficient to answer all the questions needed to validate the findings. Another limitation may relate to the timing of the last dose of oral ATP (or placebo) given. In our study the last dose was consumed 12 hours prior to testing. This contrasts with the study by Jordan et al. who studied participants after 14 days of supplementation and 3 hours cAMP post supplement dosing, and found ATP increased within group set 1 repetitions and total lifting volume [21]. Another potential GS-4997 datasheet limitation is that the study involved eumenorrheic females who were not differentiated based upon phase of the menstrual cycle. Other potential limitations include participants’ potential variation in physical

activity or diet before testing. However, participants did commit to maintaining their physical activity level for the duration of the study and to exercise restrictions for 3 days prior to testing which within a crossover design should have minimized the effect of activity on the results. Additionally, participants were required to repeat a similar dietary intake 24 h before each testing period and the testing was performed after an overnight fast which should have minimized any acute dietary effect on testing results. Conclusions In conclusion, the current study demonstrated that supplementation with 400 mg ATP/d for 15 days tended to reduce muscle fatigue while improving muscle low peak torque through Nocodazole supplier successive sets of exhaustive exercise. These effects may indicate an improvement in overall training stimulus which may have been brought about by more rapid repolarization and stronger action potentials later within sets, which should be investigated further. Electronic supplementary material Additional file 1: Table S1. Blood chemistry values before and after 15 days of supplementation with either a placebo or 400 mg ATP/d.

Appl Environ Microbiol 2010, 76:7277–7284.PubMedCrossRef 19. Xu M, Wu WM, Wu L, He Z, Van Nostrand JD, Deng Y, Luo J, Carley J, Ginder-Vogel M, Terry JG, Baouhua G, David W, Philip MJ, Terence LM, James MT, Terry H, Craig SC, Zhou J: Responses of microbial community functional structures to pilot-scale uranium in situ bioremediation. ISME J 2010, 4:1060–1070.PubMedCrossRef 20. Zhang Y, Li D, Wang H, Xiao Q, Liu

X: Molecular diversity of nitrogen-fixing bacteria in Tibet selleck chemical plateau, China. FEMS Microbiol Lett 2006, 260:134–142.PubMedCrossRef 21. Zhang Y, Li D, Wang H, Xiao Q, Liu X: The diversity of denitrifying bacteria in the alpine meadow soil of Sanjiangyuan natural reserve in Tibet Plateau. Chin Sci Bull 2006,51(8):1–8. 22. Cao G, Tang Y, Mo W, Wang Y, Li Y, Zhao X: Grazing intensity alters soil respiration in an alpine meadow on the Tibetan MK-4827 ic50 plateau. Soil Biol Biochem 2004,36(2):237–243.CrossRef 23. China Vegetation Edits Commission: China

vegetations. Beijing: Science Press; 1980. 24. Nemergut DR, Costello EK, Meyer AF, Pescador MY, Weintraub MN, Schmidt SK: Structure and function of alpine TGF-beta inhibitor and arctic soil microbial communities. Res Microbiol 2005, 156:775–784.PubMedCrossRef 25. Bao SD: Soil and agricultural chemistry analysis. Beijing: China Agriculture Press; 1999:25–150. 26. Richard AH, Qiu XY, Wu LY, Roh Y, Palumbo AV, Tiedje JM, Zhou JZ: Simultaneous recovery of RNA and DNA from soils and sediments. Appl Environ Venetoclax solubility dmso Microbiol 2001, 67:4495–4503.CrossRef 27. Wu L, Kellogg L, Devol AH, Tiedje JM, Zhou J: Microarray-based characterization of microbial community functional structure and heterogeneity in marine sediments from the gulf of Mexico. Appl Environ Microbiol 2008,74(14):4516–4529.PubMedCrossRef

28. Young JPW: Phylogenetic classification of nitrogen fixing organisms. In Biological nitrogen fixation. Edited by: Stacey G, Burries RH, Evans HJ. New York: Chapman and Hall; 1992:43–86. 29. Torsvik V, Ovreas L: Microbial diversity and function in soil: from genes to ecosystems. Curr Opin Microbiol 2002, 5:240–245.PubMedCrossRef 30. Yergeau E, Kang S, He Z, Zhou J, Kowalchuk GA: Functional microarray analysis of nitrogen and carbon cycling genes across an Antarctic latitudinal transect. ISME J 2007, 1:163–179.PubMedCrossRef 31. David AL, Steven KS: Seasonal changes in an alpine soil bacteria community in the Colorado rocky mountains. Appl Environ Microbiol 2004,70(5):2867–2879.CrossRef 32. Ross DJ, Tate KR, Scott NA, Feltham CW: Land-use change: effects on soil carbon, nitrogen and phosphorus pools and fluxes in three adjacent ecosystems. Soil Biol Biochem 1999, 31:803–813.CrossRef 33. Zhang Y, Zhang X, Liu X, Xiao Y, Qu L, Wu L, Zhou J: Microarray-based analysis of changes in diversity of microbial genes involved in organic carbon decomposition following land use/cover changes. FEMS Microbiol Lett 2007, 266:144–151.PubMedCrossRef 34.

Nano Lett 2007, 7:1649.CrossRef 6. Kobayashi T: Structural analysis of Er silicide nanowires on Si(001) using three-dimensional medium-energy ion scattering. Phys Rev B 2007, 75:125401.CrossRef

7. Chen Y, Ohlberg DAA, Williams RS: Nanowires of four epitaxial hexagonal silicides grown on Si(001). Protein Tyrosine Kinase inhibitor J Appl Phys 2002, 91:3213.CrossRef 8. Chen Y, Ohlberg DAA, Medeiros-Ribeiro G, Chang YA, Williams RS: Self-assembled growth of epitaxial erbium disilicide nanowires on silicon (001). Appl Phys Lett 2000, 76:4004.CrossRef 9. Zhu Y, Zhou W, Wang S, Ji T, Hou X, Cai Q: From nanowires to nanoislands: morphological evolutions of erbium silicide nanostructures formed on the vicinal Si(001) surface. J Appl Phys 2006, 100:114312.CrossRef 10. Liu BZ, Nogami J: A scanning tunneling microscopy study MG132 of dysprosium silicide nanowire growth on Si(001). J Appl Phys 2003, 93:593.CrossRef 11. Preinesberger C, Pruskil G, Becker SK, Dähne M, ALK inhibitor Vyalikh DV, Molodtsov SL, Laubschat C, Schiller F: Structure and electronic properties of dysprosium-silicide nanowires on vicinal Si(001). Appl Phys Lett 2005, 87:083107.CrossRef 12. Lee D, Kim S: Formation of hexagonal Gd disilicide nanowires on Si(100). Appl Phys Lett 2003, 82:2619.CrossRef 13. Harrison BC, Boland JJ: Real-time STM study of inter-nanowire reactions: GdSi2 nanowires on Si(100). Surf Sci 2005, 594:93.CrossRef 14. Nogami J, Liu BZ, Katkov MV, Ohbuchi C, Birge NO: Self-assembled

rare-earth silicide nanowires on Si(001). Phys Rev B 2001, 63:233305.CrossRef 15. Ohbuchi C, Nogami J: Holmium growth on Si(001): surface reconstructions and nanowire formation. Phys Rev B 2002, 66:165323.CrossRef 16. Lin JF, Bird JP, He Z, Bennett PA, Smith DJ: Signatures of quantum transport in self-assembled epitaxial nickel silicide nanowires. Appl Phys Lett 2004, 85:281.CrossRef 17. Bennett PA, Ashcroft B, He Z, Tromp RM: Growth dynamics of titanium silicide nanowires Methane monooxygenase observed with low-energy electron microscopy. J Vac Sci Technol B 2002, 20:2500.CrossRef 18. He Z, Stevens M, Smith DJ, Bennett PA: Epitaxial titanium silicide islands and nanowires.

Surf Sci 2003, 524:148.CrossRef 19. Stevens M, He Z, Smith DJ, Bennett PA: Structure and orientation of epitaxial titanium silicide nanowires determined by electron microdiffraction. J Appl Phys 2003, 93:5670.CrossRef 20. Zou ZQ, Li WC, Liang JM, Wang D: Self-organized growth of higher manganese silicide nanowires on Si(111), (110) and (001) surfaces. Acta Mater 2011, 59:7473.CrossRef 21. Wang D, Zou ZQ: Formation of manganese silicide nanowires on Si(111) surfaces by the reactive epitaxy method. Nanotechnology 2009, 20:275607.CrossRef 22. Zou ZQ, Wang H, Wang D, Wang QK, Mao JJ, Kong XY: Epitaxial growth of manganese silicide nanowires on Si(111)-7×7 surfaces. Appl Phys Lett 2007, 90:133111.CrossRef 23. Melosh NA, Boukai A, Diana F, Gerardot B, Badolato A, Petroff PM, Heath JR: Ultrahigh-density nanowire lattices and circuits.